Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|February 25, 2016
New-onset haematoproteinuria in a 63-year-old man with intraperitoneal lymph node enlargementAkihiro Minakawa, Shuichi Hisanaga, Yuji Sato, et al.
Nephrology (Carlton, Vic.)|March 24, 2026
Renal-Limited Cryofibrinogen-Associated Glomerulonephritis Diagnosed Using Electron MicroscopyShoko Ochiai, Akihiro Minakawa, Shuichi Hisanaga, et al.
Kidney360|April 4, 2022
Excretion Patterns of Urinary Sediment and Supernatant Podocyte Biomarkers in Patients with CKDAkihiro Fukuda, Akihiro Minakawa, Yuji Sato, et al.
Clinical Nephrology|October 13, 2021
Dural arteriovenous fistula following cerebral venous sinus thrombosis in a patient with minimal change disease: A case reportShoko Ochiai, Akihiro Minakawa, Akihiro Fukuda, et al.
Clinical and Experimental Nephrology|November 27, 2019
Urinary podocyte mRNA is a potent biomarker of anti-neutrophil cytoplasmic antibody-associated glomerulonephritisAkihiro Minakawa, Akihiro Fukuda, Masao Kikuchi, et al.
Scientific Reports|December 8, 2019
Podocyte hypertrophic stress and detachment precedes hyperglycemia or albuminuria in a rat model of obesity and type2 diabetes-associated nephropathyAkihiro Minakawa, Akihiro Fukuda, Yuji Sato, et al.
BMC Nephrology|September 24, 2020
Concurrent minimal change nephrotic syndrome and type 1 diabetes mellitus in an adult Japanese woman: a case reportRyuzoh Nishizono, Hiroki Kogou, Yuri Ishizaki, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 19, 2017
Urinary podocyte and TGF-β1 mRNA as markers for disease activity and progression in anti-glomerular basement membrane nephritisAkihiro Fukuda, Akihiro Minakawa, Yuji Sato, et al.
CEN Case Reports|December 22, 2019
A case of lupus vasculopathy presenting favorable renal outcomeYuri Ishizaki, Ayako Aizawa, Shoko Ochiai, et al.
Scientific Reports|October 24, 2020
Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathyAkihiro Fukuda, Akihiro Minakawa, Masao Kikuchi, et al.
Pageof 2